PharmaResearch Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; Rejuvenex cream, which treats the wound through rapid tissue regeneration; REJURAN HEALER, an intra dermal injection to enhance elasticity, turgidity, and tonicity of skin; Rejuran i and Rejuran s intra dermal or cannula injections; REJURAN moisturizer for daily skin protection; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel; REJURAN healing cream and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. It also provides D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; and CLEVIEL prime plus and contour plus with lidocaine medical devices, as well as CONJURAN medical devices. In addition, the company offers functional foods under the REJULINE, REJUSHINE, and REJULIGHT brands. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Seongnam, South Korea.
PharmaResearch Dividend Announcement
• PharmaResearch announced a annually dividend of ₩660.00 per ordinary share which will be made payable on 2024-04-18. Ex dividend date: 2023-12-27
• PharmaResearch annual dividend for 2023 was ₩660.00
• PharmaResearch's trailing twelve-month (TTM) dividend yield is 0.31%
• PharmaResearch's payout ratio for the trailing twelve months (TTM) is 11.54%
PharmaResearch Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2023-12-27 | ₩660.00 | annually | 2024-04-18 |
| 2022-12-28 | ₩660.00 | annually | 2023-04-14 |
| 2016-12-28 | ₩300.00 | annually | |
| 2015-12-29 | ₩200.00 | annually |
PharmaResearch Dividend per year
PharmaResearch Dividend growth
PharmaResearch Dividend Yield
PharmaResearch current trailing twelve-month (TTM) dividend yield is 0.31%. Interested in purchasing PharmaResearch stock? Use our calculator to estimate your expected dividend yield:
PharmaResearch Financial Ratios
P/E ratio24.26
PEG ratio0.24
P/B ratio4.58
ROE20.50%
Payout ratio11.54%
Current ratio3.65
Quick ratio3.02
Cash Ratio1.11
PharmaResearch Dividend FAQ
How much is the next PharmaResearch dividend?
PharmaResearch's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next PharmaResearch dividend. The next PharmaResearch dividend will be released in December.
When is PharmaResearch dividend paid?
PharmaResearch pays dividends on a annually basis. The specific dates may vary each year but are generally around December. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does PharmaResearch pay?
The specific amount of PharmaResearch dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find PharmaResearch's dividend history.
Does PharmaResearch stock pay dividends?
Yes, PharmaResearch does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find PharmaResearch's dividend history.
How much dividend does PharmaResearch pay?
PharmaResearch paid ₩0 in 2024, ₩660 in 2023, ₩660 in 2022, ₩0 in 2021, and ₩0 in 2020.
How often does PharmaResearch pay dividends?
PharmaResearch typically pays dividends on a annually basis. This means that dividends are usually distributed 1 times a year. The specific payout dates may vary each year but generally fall around December.
What is PharmaResearch's dividend yield?
The current dividend yield for PharmaResearch is 0.31%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate PharmaResearch's exact dividend yield.
When does PharmaResearch go ex dividend?
PharmaResearch's ex-dividend date for the latest dividend was on 2023-12-27. PharmaResearch typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next PharmaResearch dividend paid?
PharmaResearch pays dividends on a annually basis, typically around December, but the exact dates can vary each year.
Will PharmaResearch increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether PharmaResearch will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is PharmaResearch dividend per share?
PharmaResearch paid ₩0 per share in 2024 and ₩660 per share in 2023. The amount of dividend per share that PharmaResearch pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is PharmaResearch a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is PharmaResearch a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is PharmaResearch a dividend stock?
Yes, PharmaResearch is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is PharmaResearch a good dividend stock?
Whether PharmaResearch is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. PharmaResearch has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating PharmaResearch as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating PharmaResearch as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does PharmaResearch pay dividends monthly?
PharmaResearch typically pays dividends on a annually basis.
Does PharmaResearch pay dividends quarterly?
PharmaResearch currently pays dividends on a annually basis.
Has PharmaResearch ever paid a dividend?
Yes, PharmaResearch has a history of paying dividends to its shareholders. PharmaResearch is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy PharmaResearch dividend stocks?
To buy PharmaResearch you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy PharmaResearch stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy PharmaResearch stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does PharmaResearch pay dividends 2024?
PharmaResearch pays dividends on a annually basis. 2024 dividend payments are in 2024-04-18. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will PharmaResearch increase its dividend in 2024?
Decisions regarding PharmaResearch dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date PharmaResearch dividend overview you can look into the above table of dividend history.
How PharmaResearch dividend works?
The PharmaResearch dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how PharmaResearch's dividend process works:
1. Determination of Dividend: PharmaResearch's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, PharmaResearch publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, PharmaResearch distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from PharmaResearch are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: PharmaResearch's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, PharmaResearch publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, PharmaResearch distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from PharmaResearch are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are PharmaResearch dividends paid?
PharmaResearch dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: PharmaResearch sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, PharmaResearch distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: PharmaResearch declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: PharmaResearch sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, PharmaResearch distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: PharmaResearch declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does PharmaResearch pay dividends?
PharmaResearch typically pays dividends on a annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does PharmaResearch pay dividends?
The general pattern is that PharmaResearch pays dividends around December. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is PharmaResearch dividend safe?
The safety of PharmaResearch's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of PharmaResearch's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review PharmaResearch's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of PharmaResearch's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review PharmaResearch's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.